Abstract

The lysine acetylation state of non-histone proteins may be regulated through histone deacetylases (HDACs). Evidence suggests that NO synthase 3 (NOS3; eNOS) is post-translationally lysine acetylated leading to increased NO production in the endothelium. The purpose of this study was to test the hypothesis that NOS3 is lysine-acetylated and that upregulated HDAC1-mediated deacetylation leads to reduced NO production in endothelial cells. We determined that NOS3 is basally lysine acetylated in cultured bovine aortic endothelial cells (BAECs). In BAECs, HDAC1 is expressed in the nucleus and cytosol, and forms a novel protein-protein interaction with NOS3. Overexpression of HDAC1 in BAECs resulted in a significant reduction in NOS3 lysine acetylation (control = 1.0 ± 0.1, HDAC1 = 0.59 ± 0.08 A.U., P < 0.01), while HDAC1 knockdown with siRNA resulted in no significant change in NOS3 acetylation level. Moreover, overexpression or knockdown of HDAC1 resulted in no significant effect on NOS3 protein expression or on expression levels of NOS3 phosphorylation sites T497, S635, S1179. HDAC1 overexpression in BAECs significantly blunted basal nitrite production (an index of nitric oxide production; control 287.7 ± 29.1 pmol/mg p/h, HDAC1 172.4 ± 31.7 pmol/mg p/h, P < 0.05) as well as attenuating endothelin-1 stimulated nitrite production (control 481.8 ± 50.3 pmol/mg/h, HDAC1 243.1 ± 48.2 pmol/mg/h, P< 0.05). On the contrary, HDAC1 knockdown increased basal nitrite production (730.6 ± 99.1 pmol/mg/h), and further exaggerated increases in endothelin-1 stimulated nitrite production (1276.9 ± 288.2 pmol/mg/h). Thus, these data indicate that up-regulated HDAC1 decreases NOS3 activity, most likely, through direct lysine deacetylation of NOS3. We propose that HDAC1-mediated deacetylation of NOS3 may represent a novel target for endothelial dysfunction.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call